FDA Inspection
Mitsubishi Tanabe Pharma Development America, Inc.Mitsubishi Tanabe Pharma Development America, Inc. – FDA Inspection, Oct 15, 2021
Record Details
This FDA Inspection record concerns Mitsubishi Tanabe Pharma Development America, Inc., with an inspection on October 15, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 15, 2021
- Product Type
- Drugs
View Company Profile
ID · f7044b8b-5d0a-4038-b5b4-93419bd38f76
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1155136
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mitsubishi Tanabe Pharma Development America, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | Not classified | New Jersey District Office | |
| December 4, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mitsubishi Tanabe Pharma Development America, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.